On top of that, the pharmacology of the active factors was mainly uncharacterized, and confirmation of SCB use was hindered by an absence of recognised biomarkers. These information gaps prompted researchers throughout many disciplines to rapidly (one) monitor, recognize and quantify with chromatography/mass spectrometry the ever-transforming conte